Literature DB >> 2751723

MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus.

P von Wussow1, D Jakschies, H Hochkeppel, M Horisberger, K Hartung, H Deicher.   

Abstract

The 76-kd human interferon (IFN)-induced MX protein is the homolog to the murine protein, which is necessary and sufficient to provide adequate resistance to influenza virus infection in murine cells and in mice. Fifty-one patients with systemic lupus erythematosus (SLE) were screened for the presence of the MX homolog in mononuclear cells and for IFN and anti-IFN antibodies in serum. In 47 of 51 patients, significant levels of the MX homolog were found, while only 15 of 51 patients had measurable alpha-IFN in their serum. The IFN activity found in these sera was characterized as a partially acid-labile alpha-IFN, by means of acid-stability cross-reactivity on heterologous cells, trypsin sensitivity, and neutralization by homologous or heterologous antisera. Four of the patients had no detectable MX homolog in their leukocytes; 3 of these 4 possessed an anti-alpha-IFN antibody that was able to neutralize both a natural alpha-IFN preparation and the acid-labile IFN in SLE sera. Also, acid-labile alpha-IFN-containing SLE sera induced the MX homolog in vitro in mononuclear cells from healthy donors. These observations suggest that endogenously produced alpha-IFN is responsible for the observed induction of the MX homolog in SLE and that the IFN system is activated in more than 90% of SLE patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751723

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.

Authors:  Jamie R Flammer; Inez Rogatsky
Journal:  Mol Endocrinol       Date:  2011-04-21

2.  Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells.

Authors:  H Vallin; S Blomberg; G V Alm; B Cederblad; L Rönnblom
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 3.  Targeting interferons in systemic lupus erythematosus: current and future prospects.

Authors:  Alexis Mathian; Miguel Hie; Fleur Cohen-Aubart; Zahir Amoura
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

4.  Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options.

Authors:  Romy Strauß; Thomas Rose; Shaun M Flint; Jens Klotsche; Thomas Häupl; Markus Peck-Radosavljevic; Taketoshi Yoshida; Chieko Kyogoku; Alexandra Flechsig; Amy M Becker; Kathryn H Dao; Andreas Radbruch; Gerd-Rüdiger Burmester; Paul A Lyons; Laurie S Davis; Falk Hiepe; Andreas Grützkau; Robert Biesen
Journal:  J Mol Med (Berl)       Date:  2017-03-29       Impact factor: 4.599

5.  Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines.

Authors:  A Simon; J Fäh; O Haller; P Staeheli
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes.

Authors:  J A Rump; D Jakschiess; U Walker; M Schlesier; P von Wussow; H H Peter
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

7.  Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.

Authors:  Danika Schepis; Iva Gunnarsson; Maija-Leena Eloranta; Jon Lampa; Stefan H Jacobson; Klas Kärre; Louise Berg
Journal:  Immunology       Date:  2008-06-18       Impact factor: 7.397

8.  Characterization of B-cell lines from SLE patients and their relatives.

Authors:  T Witte; K Hartung; F M Bode; R E Schmidt; H Deicher
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.

Authors:  Scott W Canna; Julia Wrobel; Niansheng Chu; Portia A Kreiger; Michele Paessler; Edward M Behrens
Journal:  Arthritis Rheum       Date:  2013-07

Review 10.  Potential role of IFNα in adult lupus.

Authors:  Lars Rönnblom
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.